FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Fortuna Haviv

Research Profile

Chemicals & Drugs

Physiology

Molecular Mimicry

Concepts & Ideas

Structure-Activity Relationship

Anatomy

Procedures

Injections, Intravenous

Living Beings

Co-author Network

Publications

TOP 3
Jo Ann Janovick; Shaun P. Brothers; Anda Cornea; Eugene N Bush; Mark T Goulet; Wallace T Ashton; Daryl R Sauer; Fortuna Haviv; Jonathan Greer; P Michael Conn
Refolding of misfolded mutant GPCR: post-translational pharmacoperone action in vitro.
Anthony Rusk; Evelyn McKeegan; Fortuna Haviv; Sandra Majest; Jack Henkin; Chand Khanna
Preclinical evaluation of antiangiogenic thrombospondin-1 peptide mimetics, ABT-526 and ABT-510, in companion dogs with naturally occurring cancers.
Fortuna Haviv; Michael F Bradley; Douglas Kalvin; Andrew J Schneider; Donald J Davidson; Sandra Majest; Laura M McKay; Catherine J Haskell; Randy L Bell; Bach Nguyen; Kennan Marsh; Bruce W Surber; John T Uchic; James Ferrero; Yi-Chun Wang; Juan Leal; Rae Record; Jason P Hodde; Stephen F Badylak; Rick Lesniewski; Jack Henkin
Thrombospondin-1 mimetic peptide inhibitors of angiogenesis and tumor growth: design, synthesis, and optimization of pharmacokinetics and biological activities.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Fortuna Haviv (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2007: Jo Ann Janovick; Shaun P. Brothers; Anda Cornea; Eugene N Bush; Mark T Goulet; Wallace T Ashton; Daryl R Sauer; Fortuna Haviv; Jonathan Greer; P Michael Conn
Refolding of misfolded mutant GPCR: post-translational pharmacoperone action in vitro.
Molecular and cellular endocrinology 2007;272(1-2):77-85.
2006: Anthony Rusk; Evelyn McKeegan; Fortuna Haviv; Sandra Majest; Jack Henkin; Chand Khanna
Preclinical evaluation of antiangiogenic thrombospondin-1 peptide mimetics, ABT-526 and ABT-510, in companion dogs with naturally occurring cancers.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(24):7444-55.
2005: Fortuna Haviv; Michael F Bradley; Douglas Kalvin; Andrew J Schneider; Donald J Davidson; Sandra Majest; Laura M McKay; Catherine J Haskell; Randy L Bell; Bach Nguyen; Kennan Marsh; Bruce W Surber; John T Uchic; James Ferrero; Yi-Chun Wang; Juan Leal; Rae Record; Jason P Hodde; Stephen F Badylak; Rick Lesniewski; Jack Henkin
Thrombospondin-1 mimetic peptide inhibitors of angiogenesis and tumor growth: design, synthesis, and optimization of pharmacokinetics and biological activities.
Journal of medicinal chemistry 2005;48(8):2838-46.
2004: John T Randolph; Daryl R Sauer; Fortuna Haviv; Angela M Nilius; Jonathan Greer
Elimination of antibacterial activities of non-peptide luteinizing hormone-releasing hormone (LHRH) antagonists derived from erythromycin A.
Bioorganic & medicinal chemistry letters 2004;14(6):1599-602.
2004: John T Randolph; Philip Waid; Charles Nichols; Daryl R Sauer; Fortuna Haviv; Gilbert Diaz; Gary Bammert; Leslie M Besecke; Jason A Segreti; Kurt M Mohning; Eugene N Bush; Craig D Wegner; Jonathan Greer
Nonpeptide luteinizing hormone-releasing hormone antagonists derived from erythromycin A: design, synthesis, and biological activity of cladinose replacement analogues.
Journal of medicinal chemistry 2004;47(5):1085-97.
2002: Frank Reiher; Olga V Volpert; Benilde Jimenez; Susan E Crawford; Colin P N Dinney; Jack Henkin; Fortuna Haviv; Noel P Bouck; Steven C Campbell
Inhibition of tumor growth by systemic treatment with thrombospondin-1 peptide mimetics.
International journal of cancer. Journal international du cancer 2002;98(5):682-9.
1998: Fortuna Haviv; E N Bush; J Knittle; Jonathan Greer
LHRH antagonists.
Pharmaceutical biotechnology 1998;11():131-49.